New objective simple evaluation methods of amyloid PET/CT using whole-brain histogram and Top20%-Map

Chio Okuyama,Tatsuya Higashi,Koichi Ishizu,Naoya Oishi,Kuninori Kusano,Miki Ito,Shinya Kagawa,Tomoko Okina,Norio Suzuki,Hiroshi Hasegawa,Yasuhiro Nagahama,Hiroyuki Watanabe,Masahiro Ono,Hiroshi Yamauchi
DOI: https://doi.org/10.1007/s12149-024-01956-y
2024-06-23
Annals of Nuclear Medicine
Abstract:This study aims to assess the utility of newly developed objective methods for the evaluation of intracranial abnormal amyloid deposition using PET/CT histogram without use of cortical ROI analyses.
radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?
This paper aims to develop and evaluate new objective assessment methods to analyze abnormal amyloid deposition in positron emission tomography/computed tomography (PET/CT) in the brain, especially for Alzheimer's disease (AD). Traditional methods include visual judgment and the use of standardized uptake value ratio (SUVR), but these methods have limitations. The new methods include extracting skewness and mode mean ratio (MMR) parameters from the full brain histogram of PET/CT images, as well as a Top20% mapping that highlights the regions of tracer accumulation occupying 20% of the brain volume. The study retrospectively analyzed imaging data from healthy volunteers and patients diagnosed or suspected with dementia using two different amyloid PET tracers, 18F-FPYBF-2 and 11C-PiB. The results demonstrated that visually positive cases had significantly lower skewness and higher MMR. The Top20% mapping clearly showed the presence or absence of abnormal deposition. Across both tracers, all visual assessment results were consistent, and ComSUVR, skewness, and MMR showed good correlations. The new methods are simple and applicable to clinical practice, particularly the Top20% mapping, which is helpful for visual assessment of individual brain CT. Overall, this study proposes a new method that does not require cortical ROI analysis and simplifies the objective assessment of amyloid PET using histogram parameters and a Top20% mapping, which can aid in the clinical diagnosis and monitoring of amyloid deposition in diseases such as Alzheimer's disease.